- Home
- SHYF vs RGNX Comparison
SHYF vs RGNX Comparison
Compare SHYF & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHYF
- RGNX
- Stock Information
- Founded
- SHYF 1975
- RGNX 2008
- Country
- SHYF United States
- RGNX United States
- Employees
- SHYF N/A
- RGNX N/A
- Industry
- SHYF Auto Manufacturing
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHYF Consumer Discretionary
- RGNX Health Care
- Exchange
- SHYF Nasdaq
- RGNX Nasdaq
- Market Cap
- SHYF 428.3M
- RGNX 387.0M
- IPO Year
- SHYF N/A
- RGNX 2015
- Fundamental
- Price
- SHYF $10.49
- RGNX $8.85
- Analyst Decision
- SHYF Strong Buy
- RGNX Strong Buy
- Analyst Count
- SHYF 2
- RGNX 8
- Target Price
- SHYF $15.50
- RGNX $31.75
- AVG Volume (30 Days)
- SHYF 265.2K
- RGNX 1.3M
- Earning Date
- SHYF 07-24-2025
- RGNX 05-12-2025
- Dividend Yield
- SHYF 1.90%
- RGNX N/A
- EPS Growth
- SHYF 744.40
- RGNX N/A
- EPS
- SHYF 0.01
- RGNX N/A
- Revenue
- SHYF $792,886,000.00
- RGNX $156,718,000.00
- Revenue This Year
- SHYF $14.16
- RGNX $313.52
- Revenue Next Year
- SHYF $9.78
- RGNX N/A
- P/E Ratio
- SHYF $838.39
- RGNX N/A
- Revenue Growth
- SHYF N/A
- RGNX 80.70
- 52 Week Low
- SHYF $6.82
- RGNX $5.04
- 52 Week High
- SHYF $17.56
- RGNX $15.36
- Technical
- Relative Strength Index (RSI)
- SHYF 65.46
- RGNX 51.64
- Support Level
- SHYF $9.02
- RGNX $7.68
- Resistance Level
- SHYF $10.73
- RGNX $9.29
- Average True Range (ATR)
- SHYF 0.43
- RGNX 0.85
- MACD
- SHYF 0.07
- RGNX -0.08
- Stochastic Oscillator
- SHYF 85.96
- RGNX 43.42
About SHYF The Shyft Group Inc.
The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.